These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 39332020

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
    Yu L, Shen N, Shi Y, Shi X, Fu X, Li S, Zhu B, Yu W, Zhang Y.
    Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
    [Abstract] [Full Text] [Related]

  • 4. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q, Zhang P, Zhang X, Feng Y, Li L, Lin H, Yu Y.
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [Abstract] [Full Text] [Related]

  • 5. Integration of single-cell RNA-seq and bulk RNA-seq data to construct and validate a cancer-associated fibroblast-related prognostic signature for patients with ovarian cancer.
    Shen L, Li A, Cui J, Liu H, Zhang S.
    J Ovarian Res; 2024 Apr 16; 17(1):82. PubMed ID: 38627854
    [Abstract] [Full Text] [Related]

  • 6. A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts.
    Ren Q, Zhang P, Lin H, Feng Y, Chi H, Zhang X, Xia Z, Cai H, Yu Y.
    Front Immunol; 2023 Apr 16; 14():1201573. PubMed ID: 37325647
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T, Zhou Z, Xie Z, Fan X, Zhang Y, Zhang Y, Song X, Ruan Y.
    J Cancer Res Clin Oncol; 2023 Oct 16; 149(13):11379-11395. PubMed ID: 37369799
    [Abstract] [Full Text] [Related]

  • 9. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.
    Meng Z, Ren D, Zhang K, Zhao J, Jin X, Wu H.
    Aging (Albany NY); 2020 Mar 17; 12(6):5048-5070. PubMed ID: 32181755
    [Abstract] [Full Text] [Related]

  • 10. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
    Wang W, Li T, Xie Z, Zhao J, Zhang Y, Ruan Y, Han B.
    J Transl Med; 2024 Jan 14; 22(1):57. PubMed ID: 38221616
    [Abstract] [Full Text] [Related]

  • 11. Cancer-associated fibroblast-derived gene signature discriminates distinct prognoses by integrated single-cell and bulk RNA-seq analyses in breast cancer.
    Fang Z, Han YL, Gao ZJ, Yao F.
    Aging (Albany NY); 2024 May 09; 16(9):8279-8305. PubMed ID: 38728370
    [Abstract] [Full Text] [Related]

  • 12. Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma.
    Liu Y, Jian J, Zhang Y, Wang L, Liu X, Chen Z.
    Front Oncol; 2023 May 09; 13():1170893. PubMed ID: 37124542
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comprehensive scRNA-seq analysis to identify new markers of M2 macrophages for predicting the prognosis of prostate cancer.
    Ou Y, Xia C, Ye C, Liu M, Jiang H, Zhu Y, Yang D.
    Ann Med; 2024 Dec 09; 56(1):2398195. PubMed ID: 39221762
    [Abstract] [Full Text] [Related]

  • 15. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
    Li S, Chen R, Luo W, Lin J, Chen Y, Wang Z, Lin W, Li B, Wang J, Yang J.
    Comb Chem High Throughput Screen; 2022 Dec 09; 25(12):2070-2081. PubMed ID: 35048799
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W, Wang M, Wang M, Liu M.
    Medicine (Baltimore); 2023 Aug 11; 102(32):e34611. PubMed ID: 37565899
    [Abstract] [Full Text] [Related]

  • 20. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D, Lu W, Cui S, Mei H, Wu X, Zhuo Z.
    J Ovarian Res; 2022 Nov 23; 15(1):123. PubMed ID: 36424614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.